Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.

Objective: To update and expand The North American Menopause Society’s evidence-based position on nonhormonal management of menopause-associated vasomotor symptoms (VMS), previously a portion of ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Vasomotor symptoms, such as hot flashes, are widely recognized, but there are dozens of other menopausal symptoms that a woman can experience. Not All Menopausal Symptoms Are the Same, in Terms of ...

Detailed results from the Phase III OASIS-4 study have found that Bayer’s elinzanetant showed a statistically significant ...

Despite a renaissance in menopause awareness, the over-medicalisation of women’s midlife health threatens to eclipse foundational interventions like physical activity. Menopause is a pivotal milestone ...

The market has climbed by 2.0% over the past week, with every sector up, and in the last year, it has risen by 12%, showcasing a robust performance. For those interested in smaller or newer companies, ...

Switching from a diet including meat to a low-fat vegan diet reduced severe hot flashes in menopausal women by a staggering ...